In turn, anti-miR-192 therapy improved glomerular fibrosis in mouse models of diabetic nephropathy via a simultaneous reducing of collagen and fibronectin levels in the mesangial cells [38, 135]. Here, FN1 is linked to diabetic kidney disease.